The EDC is live today — see what ships now
All studies
NCT07666841From ClinicalTrials.govRecruiting

Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

Tele-Pulmonary Rehabilitation to Improve Adherence and Management of Patients With Chronic Lung Diseases

  • COPD (Chronic Obstructive Pulmonary Disease)
  • Rehabilitation
  • Bronchiectasis Adult
  • Pulmonary Arterial Hypertension (PAH)
  • Interstitial Lung Disease (ILD)

At a glance

Phase
Phase not stated
Study type
Interventional
Sponsor
Tel-Aviv Sourasky Medical Center
Enrolment target
90
Started
1 July 2026
Main results due
1 July 2028
Study sites
2
Registry updated
24 September 2026

Can you take part?

  • Aged 18 years and over.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

1. Patients meeting the Israeli Health Basket criteria for reimbursement of pulmonary rehabilitation (PR), including one of the following conditions:

   * COPD with an FEV1 below 50% or with severe exacerbation (hospitalization) in the previous year or two moderate exacerbations in the previous year.
   * Interstitial lung disease with an FVC below 80% or a DLCO below 60%.
   * Bronchiectasis with at least two exacerbations in the past year or at least one hospitalization, and an FEV1 below 80%.
   * Pulmonary arterial hypertension.
2. Willingness to initiate a PR or Tele-PR (TPR) programs.
3. Ability to perform the TPR program or traditional PR activities as assessed by a member of the study team prior to enrollment.
4. Agree to participate, with signed informed consent.

Exclusion Criteria:

1. Uncontrolled comorbidity (e.g uncontrolled congestive heart failure)
2. Inability to operate the mobile application.
3. Without a mobile device or computer.
4. A hospitalization in the 2-months prior to randomization.
5. Completed PR program in the last 12 months.
6. Inability to complete 10 repetitions in the 1-minute sit-to-stand test or 5-second single-leg stance
7. Pregnancy
8. Inability to provide informed consent due to impaired decision-making capacity, as determined by the study's capacity assessment.

What this study is about

In the sponsor’s own words, from the registry.

Pulmonary rehabilitation is a key treatment for lung diseases, but many patients struggle to attend sessions due to travel distances, physical limitations, or logistical barriers. The purpose of this study is to evaluate whether a tele-pulmonary rehabilitation (TPR) program can improve the rates of treatment initiation and adherence among patients with chronic lung diseases compared to traditional, center-based pulmonary rehabilitation. Additionally, the study will assess improvements in quality of life, physical symptoms, and safety in both groups.

This study will enroll 90 patients from two medical centers in Israel (Tel Aviv and Barzilai). Participants will be randomly assigned to one of two groups:

1. The control group will receive usual care with a referral by a pulmonologist to standard pulmonary rehabilitation at a medical center. 2. The intervention group will participate in a supervised remote tele-rehabilitation program using a dedicated application and remote monitoring.

Study sites(2)

  • Barzilai Medical Center

    Ashkelon, Israel

    Recruiting

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

    Recruiting

Showing 2 of 2 sites. 2 of the 2 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07666841. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases | Trialion